Venture Capital Investors

Parker Institute for Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy is a VC investing group that assists its portfolio companies by accelerating their success.

Venture Investor Overview

Contact Information

Background Information

Overview

We combined forces with the brightest minds in the field to radically change the way research is done -- to save lives faster. Our model is designed to remove barriers, encourage collaboration and turn ideas into real-world cancer treatments.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/9/2023

Transaction History

Our records indicate that Parker Institute for Cancer Immunotherapy invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Founder

Sean Parker

        

Executive Director

Michael Polansky

        

Founding Partner

Tom van Loben Sels

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Parker Institute for Cancer Immunotherapy has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Park+ | Parker Price Venture Capital

Share this article

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary